
Identification of NF-κB inhibitors following Shenfu injection and bioactivity-integrated UPLC/Q-TOF-MS and screening for related anti-inflammatory targets in vitro and in silico
Keywords: BMC; Benzoyl-mesaconine; CAD; Coronary artery disease; CHD; Coronary heart disease; DEX; Dexamethasone; DMEM; Dulbecco's modified Eagle's Medium; ELISA; Enzyme-linked immunosorbent assay; ESI; Electrospray ionization; FBS; Fetal bovine serum; FUZ; Fuzil